HPV - human papillomavirus
HPV is a dangerous virus that causes cancer of the head, neck, and genital area, as well as cervical cancer in women.

HPV, or human papillomavirus, is very common in Estonia—four out of five people will be infected with some strain of HPV at least once in their lifetime. HPV is a dangerous virus that causes cancer—in the head, neck, and genital areas, and in women, cervical cancer. It is easy to become infected; the virus spreads from person to person through skin-to-skin contact or contact with mucous membranes. Infection can occur, for example, during sexual intercourse, but even simple intimate contact is sufficient.
HPV strains are divided into low-risk and high-risk strains.
Most HPV strains are low-risk. These cause benign changes on the skin and mucous membranes, such as warts or genital warts.
High-risk strains can cause cancer: in the genital area, cervical, vulvar, vaginal, anal, and penile cancer; and in the oral cavity, oral and throat cancer.
HPV is not hereditary – the risk of infection is not influenced by genes or a family history of the disease.
Prevention
You can protect yourself against HPV through vaccination. The vaccine is most effective when administered between the ages of 12 and 14, and in Estonia, it is free for all young people aged 12–18. Read more about vaccinating children.
HPV vaccination usually takes place at school—this is a good opportunity to protect yourself against the virus. Vaccination is voluntary; for 12–17-year-olds, vaccination requires written consent from a parent or guardian. 18-year-olds can make the decision independently.
Adults can also get vaccinated for a fee at a pharmacy and a family health center.
The vaccine provides the best protection against HPV, especially if administered before the onset of sexual activity. Using condoms reduces the risk of infection but does not guarantee protection, as infection can still occur through contact with skin not covered by a condom.
The vaccination course consists of one dose. Young people with immunodeficiency require a three-dose vaccination series.
The Gardasil 9 vaccine used in Estonia protects against the nine most dangerous HPV strains. Since there are over 200 HPV strains, 15 of which are high-risk, it is important to undergo regular screening even after vaccination.
The vaccine helps prevent diseases caused by these HPV strains, such as precancerous conditions and cancer of the cervix, vulva, vagina, and anus, as well as genital warts (genital condylomas). In particular, the vaccine protects against HPV types 16 and 18, which account for 70% of all cervical cancer cases.
The vaccine provides the best protection against HPV, especially if administered before the onset of sexual activity. Using condoms reduces the risk of infection but does not guarantee protection, as infection can still occur through contact with skin not covered by a condom.
The vaccination course consists of one dose. Young people with immunodeficiency require a three-dose vaccination series.
The Gardasil 9 vaccine used in Estonia protects against the nine most dangerous HPV strains. Since there are over 200 HPV strains, 15 of which are high-risk, it is important to undergo regular screening even after vaccination.
The vaccine helps prevent diseases caused by these HPV strains, such as precancerous conditions and cancer of the cervix, vulva, vagina, and anus, as well as genital warts (genital condylomas). In particular, the vaccine protects against HPV types 16 and 18, which account for 70% of all cervical cancer cases.
HPV and Cancer Risk
Most HPV infections clear up on their own within two years. In cases of long-term infection, HPV can lead to precancerous conditions or cause cancer.
There is a common misconception that HPV affects only women. In men, the virus can cause penile, anal, and oropharyngeal cancer. Every year, 625,600 women and 69,400 men worldwide are diagnosed with HPV-related cancers. HPV infection accounts for about 5% of all cancer cases worldwide.
Cervical cancer is caused by long-term HPV infection in almost all cases. In Estonia, the incidence of cervical cancer is one of the highest in the European Union; for example, in 2018, the incidence of cervical cancer in Estonia was nearly twice the European Union average.
Widespread vaccination coverage also reduces the spread of the virus.
Vaccination does not replace women’s screening or early treatment when necessary.
Most HPV infections clear up on their own within two years. In cases of long-term infection, HPV can lead to precancerous conditions or cause cancer.
There is a common misconception that HPV affects only women. In men, the virus can cause penile, anal, and oropharyngeal cancer. Every year, 625,600 women and 69,400 men worldwide are diagnosed with HPV-related cancers. HPV infection accounts for about 5% of all cancer cases worldwide.
Cervical cancer is caused by long-term HPV infection in almost all cases. In Estonia, the incidence of cervical cancer is one of the highest in the European Union; for example, in 2018, the incidence of cervical cancer in Estonia was nearly twice the European Union average.
Widespread vaccination coverage also reduces the spread of the virus.
Vaccination does not replace women’s screening or early treatment when necessary.
HPV infection and cervical cancer can be detected early through screening.
In Estonia, women aged 30–65 are invited every five years to cervical cancer screening. The screening uses an HPV test, which helps detect the presence of the virus on the cervix. A Pap test is also used to detect precancerous cell changes on the cervix.
FYI
Cervical cancer is the fourth most common cancer among women. In 2020, over 600,000 new cases were diagnosed worldwide, and over 300,000 women died as a result.
In Estonia, both the incidence and mortality rates for cervical cancer have remained relatively stable over the past couple of decades. Most cases in Estonia are diagnosed in women over 55 years of age.
FYI
Cervical cancer is the fourth most common cancer among women. In 2020, over 600,000 new cases were diagnosed worldwide, and over 300,000 women died as a result.
In Estonia, both the incidence and mortality rates for cervical cancer have remained relatively stable over the past couple of decades. Most cases in Estonia are diagnosed in women over 55 years of age.
Frequently Asked Questions
Yes, they have been thoroughly studied and are safe.
Yes, 15 types of HPV are known to cause cancer.
HPV is one of the most common infections.
HPV spreads through skin-to-skin or mucous membrane contact.
The virus can remain in the body for a long time without causing any symptoms.
Vaccination helps prevent 90% of diseases caused by HPV infection.
The best solution is vaccination before becoming sexually active.
In Estonia, young people aged 12–18 are vaccinated free of charge.
The vaccine does not contain live virus and does not cause disease.
Gardasil 9 protects against nine strains of HPV.
No separate medical checkup is required before vaccination.
No separate health check-up is required after vaccination.
The vaccine is contraindicated for those who are hypersensitive to any of the vaccine’s ingredients.
Side effects are usually mild and resolve within a few hours or days.
Severe side effects are very unlikely.
The vaccine contains small amounts of adjuvants.
Very effective.
Yes, but the sooner you get vaccinated, the better.
HPV causes cancer in men as well.
Cervical cancer isn’t hereditary—the fact that you don’t have it doesn’t protect your daughter.
No, it does not.
Yes, vaccination is voluntary.
80% of unvaccinated people will be infected with at least one strain of HPV during their lifetime.
Further reading
- A study confirms the vaccine’s effectiveness even 12 years after vaccination (2020);
- News from the International Agency for Research on Cancer.
- A study confirms the vaccine’s effectiveness even 12 years after vaccination (2020);
- News from the International Agency for Research on Cancer.
- A study confirms the vaccine’s effectiveness even 12 years after vaccination (2020);
- News from the International Agency for Research on Cancer.
- A study confirms the vaccine’s effectiveness even 12 years after vaccination (2020);
- News from the International Agency for Research on Cancer.